Summary of opinion: Kisqali, 17/10/2024 Positive

Human medicines European public assessment report (EPAR): Zytiga, abiraterone, Date of authorisation: 05/09/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Velcade, bortezomib, Date of authorisation: 26/04/2004, Revision: 46, Status: Authorised

Medicinal products for human use: monthly figures - September 2024

Training webinar on Product Management Service (PMS) Product User Interface (PUI), Online, from 16 October 2024, 10:00 (CEST) to 16 October 2024, 11:00 (CEST)

Human medicines European public assessment report (EPAR): Ciambra, pemetrexed, Date of authorisation: 02/12/2015, Revision: 7, Status: Withdrawn (authorisation)

Babesia (B. microti, B, duncani, B. divergens, and B. venatorum) DNA and RNA - Notified body 2797 - 19/11/2021 - View in the context of the performance evaluation consultation procedure (PECP)

Human medicines European public assessment report (EPAR): Pregabalin Zentiva, pregabalin, Date of authorisation: 17/07/2015, Revision: 18, Status: Authorised

Shoulder prostheses - Notified body 0459 - 25/08/2022 - Expert decision and opinion in the context of the clinical evaluation consultation procedure (CECP)

Medical device expert panels